Simulation studies reveal how acyl-lysine binds to bacterial membranes, suggesting new antimicrobial strategies.
Antibiotic resistance has been widely recognized as a global threat to public health, calling for alternative antimicrobial agents. Here, we focused on acyl-lysine, a biomimetic polymer with proven antimicrobial activity. Using atomic-scale computer simulations, we show that the binding of acyl-lysine to model bacterial membranes is a two-step process. The first step is the electrostatic attraction of cationic acyl-lysine to anionic membranes. The second step is the embedding of the dodecanoyl N-terminal tail of acyl-lysine into the membrane's hydrophobic core, which makes the long hydrophobic tail a molecular anchor and stabilizes the binding. This anchor was found to be critical for embedding acyl-lysine oligomers with relatively short acyl spacers (aminobutyryl-lysine and aminooctanoyl-lysine repeating units): cutting off the hydrophobic tail made the insertion of these oligomers into the membrane less deep, which can be linked to lower antimicrobial activity. In turn, acyl-lysine oligomers with long acyl spacers (aminododecanoyl-lysine monomers) form a highly structured aggregate, which represents a stack of intrinsically ordered oligomers. Such aggregates strongly suppress embedding of the oligomers into the bacterial membrane. Overall, our computational findings offer a molecular-level interpretation of experimental data for the antimicrobial activity of acyl-lysine and can be used for the further development of antimicrobial agents to overcome antibiotic resistance.
No takes yet. Share an insight, caveat, or question.
Gurtovenko et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: